Innovative Payment Models for Gene Therapies

EP: 1.Overview of Gene Therapy Approaches and Impacts

EP: 2.Key Factors in Gene Vector Selection

EP: 3.Viral Vectors in Gene Therapy

EP: 4.Navigating Gene Therapy Eligibility: The Role of Genetic Testing

EP: 5.Evaluating Transformative Gene Therapies

EP: 6.Shifting the Treatment Paradigm in Spinal Muscular Atrophy

EP: 7.Developments in Muscular Dystrophy Gene Therapy

EP: 8.Review of Clinical Evidence for Delandistrogene Moxeparvovec for DMD

EP: 9.Driving Clinical Insights: Harnessing Functional Assessments in DMD Research

EP: 10.Duchenne Muscular Dystrophy Treatment Landscape Review

EP: 11.Strategic Insights Into Evolving Gene Therapy Trends

EP: 12.Sustainable Gene Therapy Coverage Approaches

EP: 13.Interpreting Clinical Data to Guide Coverage Decisions for Rare Disease Therapies

EP: 14.Coverage of Gene Therapies: Balancing Cost, Clinical Impact, and Durability of Effect

Now Viewing

EP: 15.Innovative Payment Models for Gene Therapies

EP: 16.Ethical Implications of Patient Access Restrictions

EP: 17.Enhancing Collaboration for Patient-Centered Care in Rare Diseases

This is a video synopsis/summary of a Peer Exchange involving Ryan Haumschild, PharmD, MS, MBA; Jessica Nance, MD, MS; Kimberly C. Chen, DO, MSHLM; Emma Ciafaloni, MD, FAAN; and Mary Pak, MD, FACP.

Haumschild delves into alternative payment models like subscription plans and warranties with Chen, examining their potential to enhance patient access and ensure financial viability for cell and gene therapies. Chen explains how subscription models offer predictability for payers and enable cost sharing among stakeholders, while warranties function similarly to product warranties, ensuring therapy effectiveness. However, concerns about budget constraints and legal adjustments accompany subscription models. Chen also outlines performance-based contracts, annuity models, and outcome-based payments as additional strategies. These approaches shift financial risk and incentivize positive treatment outcomes, fostering innovative solutions to afford costly therapies. As the discussion concludes, the focus remains on optimizing patient care while navigating the complexities of financing advanced medical treatments.

Video synopsis is AI-generated and reviewed by AJMC^® editorial staff.